Cargando…

Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic

INTRODUCTION: To overcome travel restrictions during the COVID-19 pandemic, consumer-based technology was rapidly deployed to the smartphones of individuals with Parkinson's disease (PD) participating in a 12-month exercise trial. The aim of the project was to determine the feasibility of utili...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Jay L., Koop, Mandy Miller, McGinley, Marisa P., Penko, Amanda L., Fernandez, Hubert H., Shook, Steven, Bermel, Robert A., Machado, André, Rosenfeldt, Anson B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035908/
https://www.ncbi.nlm.nih.gov/pubmed/33868630
http://dx.doi.org/10.1155/2021/5534282
_version_ 1783676800215285760
author Alberts, Jay L.
Koop, Mandy Miller
McGinley, Marisa P.
Penko, Amanda L.
Fernandez, Hubert H.
Shook, Steven
Bermel, Robert A.
Machado, André
Rosenfeldt, Anson B.
author_facet Alberts, Jay L.
Koop, Mandy Miller
McGinley, Marisa P.
Penko, Amanda L.
Fernandez, Hubert H.
Shook, Steven
Bermel, Robert A.
Machado, André
Rosenfeldt, Anson B.
author_sort Alberts, Jay L.
collection PubMed
description INTRODUCTION: To overcome travel restrictions during the COVID-19 pandemic, consumer-based technology was rapidly deployed to the smartphones of individuals with Parkinson's disease (PD) participating in a 12-month exercise trial. The aim of the project was to determine the feasibility of utilizing a combined synchronous and asynchronous self-administered smartphone application to characterize PD symptoms. METHODS: A synchronous video virtual visit was completed for the administration of virtual Movement Disorder Society-Unified Parkinson's Disease Rating Scale III (vMDS-UPDRS III). Participants asynchronously completed a mobile application consisting of a measure of upper extremity bradykinesia (Finger Tapping Test) and information processing. RESULTS: Twenty-three individuals completed the assessments. The mean vMDS-UPDRS III was 23.65 ± 8.56 points. On average, the number of taps was significantly greater for the less affected limb, 97.96 ± 17.77 taps, compared to the more affected, 89.33 ± 18.66 taps (p = 0.025) with a significantly greater number of freezing episodes for the more affected limb (p < 0.05). Correlation analyses indicated the number of errors and the number of freezing episodes were significantly related to clinical ratings of vMDS-UPDRS III bradykinesia (Rho = 0.44, p < 0.01; R = 0.43, p < 0.01, resp.) and finger tapping performance (Rho = 0.31, p = 0.03; Rho = 0.32, p = 0.03, resp.). Discussion. The objective characterization of bradykinesia, akinesia, and nonmotor function and their relationship with clinical disease metrics indicate smartphone technology provides a remote method of characterizing important aspects of PD performance. While theoretical and position papers have been published on the potential of telemedicine to aid in the management of PD, this report translates the theory into a viable reality.
format Online
Article
Text
id pubmed-8035908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80359082021-04-15 Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic Alberts, Jay L. Koop, Mandy Miller McGinley, Marisa P. Penko, Amanda L. Fernandez, Hubert H. Shook, Steven Bermel, Robert A. Machado, André Rosenfeldt, Anson B. Parkinsons Dis Research Article INTRODUCTION: To overcome travel restrictions during the COVID-19 pandemic, consumer-based technology was rapidly deployed to the smartphones of individuals with Parkinson's disease (PD) participating in a 12-month exercise trial. The aim of the project was to determine the feasibility of utilizing a combined synchronous and asynchronous self-administered smartphone application to characterize PD symptoms. METHODS: A synchronous video virtual visit was completed for the administration of virtual Movement Disorder Society-Unified Parkinson's Disease Rating Scale III (vMDS-UPDRS III). Participants asynchronously completed a mobile application consisting of a measure of upper extremity bradykinesia (Finger Tapping Test) and information processing. RESULTS: Twenty-three individuals completed the assessments. The mean vMDS-UPDRS III was 23.65 ± 8.56 points. On average, the number of taps was significantly greater for the less affected limb, 97.96 ± 17.77 taps, compared to the more affected, 89.33 ± 18.66 taps (p = 0.025) with a significantly greater number of freezing episodes for the more affected limb (p < 0.05). Correlation analyses indicated the number of errors and the number of freezing episodes were significantly related to clinical ratings of vMDS-UPDRS III bradykinesia (Rho = 0.44, p < 0.01; R = 0.43, p < 0.01, resp.) and finger tapping performance (Rho = 0.31, p = 0.03; Rho = 0.32, p = 0.03, resp.). Discussion. The objective characterization of bradykinesia, akinesia, and nonmotor function and their relationship with clinical disease metrics indicate smartphone technology provides a remote method of characterizing important aspects of PD performance. While theoretical and position papers have been published on the potential of telemedicine to aid in the management of PD, this report translates the theory into a viable reality. Hindawi 2021-04-10 /pmc/articles/PMC8035908/ /pubmed/33868630 http://dx.doi.org/10.1155/2021/5534282 Text en Copyright © 2021 Jay L. Alberts et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Alberts, Jay L.
Koop, Mandy Miller
McGinley, Marisa P.
Penko, Amanda L.
Fernandez, Hubert H.
Shook, Steven
Bermel, Robert A.
Machado, André
Rosenfeldt, Anson B.
Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
title Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
title_full Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
title_fullStr Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
title_full_unstemmed Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
title_short Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
title_sort use of a smartphone to gather parkinson's disease neurological vital signs during the covid-19 pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035908/
https://www.ncbi.nlm.nih.gov/pubmed/33868630
http://dx.doi.org/10.1155/2021/5534282
work_keys_str_mv AT albertsjayl useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT koopmandymiller useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT mcginleymarisap useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT penkoamandal useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT fernandezhuberth useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT shooksteven useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT bermelroberta useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT machadoandre useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic
AT rosenfeldtansonb useofasmartphonetogatherparkinsonsdiseaseneurologicalvitalsignsduringthecovid19pandemic